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Abstract
This study aimed to analyse trends in notifiable infectious diseases in China, in their historical context. Both English and
Chinese literature was searched and diseases were categorised according to the type of disease or transmission route.
Temporal trends of morbidity and mortality rates were calculated for eight major infectious diseases types. Strong
government commitment to public health responses and improvements in quality of life has led to the eradication or
containment of a wide range of infectious diseases in China. The overall infectious diseases burden experienced a dramatic
drop during 1975–1995, but since then, it reverted and maintained a gradual upward trend to date. Most notifiable diseases
are contained at a low endemic level; however, local small-scale outbreaks remain common. Tuberculosis, as a bacterial
infection, has re-emerged since the 1990s and has become prevalent in the country. Sexually transmitted infections are in a
rapid, exponential growth phase, spreading from core groups to the general population. Together human
immunodeficiency virus (HIV), they account for 39% of all death cases due to infectious diseases in China in 2008.
Zoonotic infections, such as severe acute respiratory syndrome (SARS), rabies and influenza, pose constant threats to
Chinese residents and remain the most deadly disease type among the infected individuals. Therefore, second-generation
surveillance of behavioural risks or vectors associated with pathogen transmission should be scaled up. It is necessary to
implement public health interventions that target HIV and relevant coinfections, address transmission associated with
highly mobile populations, and reduce the risk of cross-species transmission of zoonotic pathogens.
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Introduction
China has experienced a large decline in the spread and burden
of infectious diseases since the early 1960s, associated with effective
and large-scale public health interventions and large population-
based vaccination programmes. China successfully eliminated 11
infectious diseases – including smallpox from the general Chinese
population in early 1960s [1], 19 years before its global eradication
– and another 10 infectious diseases, including poliomyelitis, have
more recently been eliminated [2]. A further 13 diseases, including
measles, are thought to be contained well at low endemic levels
[3].
Surveillance systems for infectious diseases in China are mainly
hospital based. The latest available statistics (from 2006) indicate
that China has 18,703 county hospitals, 40,907 township hospitals
and 201,562 medical clinics [4,5]. Hospitals at the prefecture level
or above are usually equipped with reference laboratories that are
capable of carrying out molecular surveillance for cases. Together
with laboratories from academic institutions, they form the front
line of surveillance for outbreak detection and notification of
infectious diseases in China. All hospitals and clinics are obliged to
report both suspected and confirmed cases of notifiable infectious
disease to their nominated county Centre for Disease Control
(CDC). After recording the details of the reported cases (including
their geographical location, demographicl information and
infection status), county CDCs send the information to the
country’s central CDC, through the National Infectious Diseases
Monitoring Information System Database, which was established
in 2004 [6]. This reporting mechanism bypasses the previous
stepwise hierarchical reporting framework, thus allowing informa-
tion to flow directly from grassroots CDCs to China’s central
disease database. However, regional, provincial and national
CDCs do not have equal access to all of the data in the database:
their access rights are limited to their own administrative regions,
and only national CDCs has the full access to all data [7]. In
addition to their responsibility for verifying the disease information
from their administrative regions, municipal and provincial CDCs
are required to report to the appropriate level of the Bureaus of
Health or Department of Health and to form networks with local
research bodies, universities and other health organisations. At the
top of the hierarchy, China’s central CDC is the overseeing
organisation with responsibility for assembling and analysing
diagnostic data for all diseases and then presenting a final report to
the Ministry of Health, which is the main public health
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office for disseminating infectious disease information to the
public, but provincial and municipal CDCs are also authorised to
publicise the information to people in their jurisdiction, under the
supervision of the Ministry of Health [8]. In contrast to disease
surveillance systems in Europe, the Chinese surveillance system
uses a multilayer administrative mechanism that enables rapid and
efficient upward flow of epidemic information.
China is a populous country of 1.3 billion people [9]. Over the
last 30 years of economic reform in the country, there have been
environmental, demographic, social and behavioural changes in
the population. As China’s ties with the rest of world become
increasingly strong, infectious diseases in China no longer remain
a domestic issue. A thorough review of infectious disease
surveillance in China is timely and important for the country’s
disease prevention and control strategies. Currently, 39 infectious
diseases are classified as notifiable in China. This study reviews
trends in notifiable infectious diseases in China, in their historical
context, discusses the current epidemiological state of these
infections and their implications for disease surveillance and
public health interventions. The review is structured by category of
disease or transmission route.
Methods
Currently, 39 infectious diseases are notifiable in China,
classified as A, B or C according to their epidemic levels and
potential population threats. Groups A and B (total 28 diseases)
represent categories of diseases with high risk of outbreaks or that
are likely to result in rapid spread once an outbreak occurs.
Mortality and morbidity related to group A and B diseases are
reported and published by the Chinese Ministry of Health on a
monthly basis. Group C diseases are less infectious and, when
outbreaks occur, are epidemiologically less severe. They are
required to be reported only when outbreaks occur.
In this review, we searched published peer-reviewed research
articles as well as online reports and grey literature from 1985 to
2010 relevant to disease surveillance in China in the following
databases: PubMed, Chinese Scientific Journals Fulltext Database
(CQVIP), China National Knowledge Infrastructure (CNKI) and
Wanfang Data. Keywords used in the database search included
[‘Chinese’ or ‘China’] and [‘Infectious diseases surveillance’ or
‘surveillance system’ or ‘infectious diseases monitoring’ or
‘infectious diseases information’ or the type of infectious disease
or the name of individual infectious diseases]. We also searched
governmental reports, reports of non-governmental organisations
and other grey literature from online sources. We then collated
data on notified cases and mortality related to these diseases, using
the latest available information from the Ministry of Health [10].
Notifiable infectious disease data, including morbidity and
mortality rates, was summarised by Chinese Ministry of Health
and published annually in Chinese Health Yearbook and online
accessible through CNKI database. Notably, this dataset does not
contain data on SARS and influenza A(H5N1) virus infection.
Hence we did not include them in our statistical analysis, but
describe them in the text.
The selected diseases were categorised into eight major types
according to their diseases characteristics and origins. The
morbidity and mortality for each disease type were calculated as
the sum of the corresponding rates of individual diseases. The total
number of diagnosed and death cases were estimated by
multiplying morbidity and mortality rates by the overall Chinese
population in the study years. Case fatality rate was defined as the
percentage of persons diagnosed with the disease who die as a
result of the illness during the calendar year, and was estimated by
dividing mortality rate by morbidity rate of the diseases. Further,
for each individual disease, we calculate the disease-specific
mortality rates among the Chinese population in five-year intervals
(1999–2003 and 2004–2008). For each disease, the mean annual
increase or decrease during 1999–2008, with 95% confidence
intervals, is estimated, based on linear regression of logarithmic
values of the number of annual death cases.
Results and Discussion
Trends in infectious diseases in China, 1999–2008
Morbidity of notifiable infectious diseases in China, represented
by estimated numbers of new cases, declined substantially (.90%)
from 22,000 cases per million in 1975 to a nadir level of 1,800
cases per million in 1995 (Figure 1a). Since then, the rate of new
infectious disease cases gradually reverted and maintained an
upward trend. In 2008, the estimated rate of infectious diseases
among the general Chinese population reached over 3000 cases
per million population. The composition of diagnosed diseases
cases also changed substantially, in 1975, the three most reported
diseases were gastrointestinal diseases (41.9%), vector-borne
diseases (30.8%) and vaccine-preventable diseases (21.1%),
corresponding to a total of 93.8% of all diagnosed cases
(Figure 1a). Additionally, these three types of diseases account
for 35.5, 21.7 and 18.4 million reported cases respectively during
the period 1975–1979 (Table 1). In contrast, in 1995, although
gastrointestinal diseases remained the dominating disease type
(41.6%), the proportion of all cases that were due to viral hepatitis
quickly rose to 35.7%. Sexually transmitted diseases re-emerged,
and together with HIV, consisted of a substantial 6.3% of all
reported cases. In 2008, the three most frequently reported disease
types included viral hepatitis (38.3%), bacterial infections (33.3%)
and STIs and HIV (9.8%), which account for 5.4, 4.8 and 1.4
million diagnosed cases respectively during the period 2005–2008
(Table 1).
Rapid declines in infectious diseases mortality and its similar
saddle pattern were also observed in the past 35 years. The overall
mortality rate in China decreased from 66 cases per million in
1975 to 5 cases per million in 1995, then it gradually reverted to
10 cases per million in 2008 (Figure 1b). Vaccine-preventable
diseases, bacterial infections and gastrointestinal diseases were the
greatest causes of death, accounting for 30.0%, 24.0% and 19.5%
of reported infectious diseases death cases among Chinese
population in 1975 (Figure 1b). However, the rank of composition
shifted to zoonoses (22%), viral hepatitis (17.3%) and quarantin-
able diseases (15.3%) in 1995. Since then, the proportion of deaths
caused by STIs and HIV, and bacterial infections rapidly
increased. By 2008, STIs and HIV (39.5%) has become the
mostly deadly infectious disease, followed by bacterial infections
(24.7%) and zoonoses (20.0%). During the period 2005–2008,
these three types of diseases have led to approximately 12,500,
13,300 and 11,400 deaths in China, respectively (Table 1).
Case fatality rate measures the percentage of deaths among
people who contracted a disease. During 1975–2008, the disease
type with the highest fatality rate is zoonoses, consistently causing
5–15% of deaths among the infected population. Following that,
quarantinable diseases killed 1.4–5.6% of its infected population
during the same period. In comparison, fatality rates in vaccine-
preventable (0.112% during 2005–2008), gastrointestinal diseases
(0.036%), bacterial infections (0.277%) and viral hepatitis (0.086%)
show clear decreasing trends in China, corresponding to 3.5, 3.6,
12.4 and 2.4 folders reduction in comparison with the period
1975–1979, respectively. However, fatality of STIs and HIV
Trends in Infectious Diseases in China
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31076Figure 1. Temporal trend of morbidity and mortality rates, and their composition, of the eight major notifable infectious disease
types in China.
doi:10.1371/journal.pone.0031076.g001
Trends in Infectious Diseases in China
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e31076increased to 0.894% during 2005–2008, doubling the level in
1985–1989 (Table 1).
Quarantinable diseases
Plague, cholera and epidemic haemorrhagic fever (which is
caused by hantaviruses and mainly transmitted by rodents) have
had diverse impacts on the Chinese population at different
stages of recent history. During 1944 to 1949, there were 179
notified outbreaks of plague across China, which resulted in an
estimated 2.4 million deaths. From 1950 to 1954, the mean
number of annual notifications of plague infection was 1,373
cases per year [11,12]. This was then substantially reduced to 20
cases per year over the following 30 to 40 years. Since 1990, the
number of annual reported plague cases has increased to
approximately 52, which is equivalent to 0.004 per 100,000
population per year [11,12]. There is no observed trend in the
Table 1. Estimated number of diagnosed cases, death cases and case fatality rate of eight major infectious disease types in China
in 5-year intervals.
Period 1975–1979 1980–1984 1985–1989 1990–1994 1995–1999 2000–2004 2005–2008
Quarantinable diseases
Diagnosed cases 146,271 435,073 410,779 277,005 273,160 156,579 57,735
Death cases 8,190 14,694 10,636 5,879 3,757 2,192 1,382
Case fatality rate (%) 5.599% 3.377% 2.589% 2.122% 1.375% 1.400% 2.393%
[lower-upper limits] [5.419–5.779%] [3.295–3.458%] [2.515–2.664%] [2.040–2.204%] [1.309–1.442%] [1.311–1.489%] [2.202–2.584%]
Vaccine-preventable
Diagnosed cases 18,380,894 6,759,577 1,360,323 597,181 1,383,591 1,583,847 1,255,778
Death cases 72,545 28,885 7,085 3,130 3,987 3,684 1,409
Case fatality rate (%) 0.395% 0.427% 0.521% 0.524% 0.288% 0.233% 0.112%
[lower-upper limits] [0.390–0.399%] [0.420–0.435%] [0.502–0.539%] [0.496–0.552%] [0.274–0.302%] [0.221–0.244%] [0.103–0.121%]
STIs & HIV
Diagnosed cases – – 25,447 455,258 1,047,612 1,315,529 1,401,467
Death cases – – 108 1,568 1,763 2,838 12,533
Case fatality rate (%) – – 0.426% 0.344% 0.168% 0.216% 0.894%
[lower-upper limits] [0.304–0.549%] [0.318–0.370%] [0.156–0.180%] [0.204–0.228%] [0.870–0.918%]
Gastrointestinal diseases
Diagnosed cases 35,552,854 27,701,730 13,159,721 5,536,107 3,834,567 2,613,811 1,644,061
Death cases 46,153 23,698 13,909 5,257 2,230 1,298 593
Case fatality rate (%) 0.130% 0.086% 0.106% 0.095% 0.058% 0.050% 0.036%
[lower-upper limits] [0.128–0.132%] [0.084–0.087%] [0.103–0.108%] [0.091–0.099%] [0.054–0.062%] [0.046–0.054%] [0.032–0.040%]
Bacterial Infections
Diagnosed cases 2,258,134 1,047,059 503,691 202,619 1,476,435 3,363,049 4,820,142
Death cases 78,491 30,151 16,081 3,119 4,205 5,908 13,330
Case fatality rate (%) 3.476% 2.880% 3.193% 1.540% 0.285% 0.176% 0.277%
[lower-upper limits] [3.439–3.512%] [2.831–2.919%] [3.118–3.267%] [1.458–1.622%] [0.272–0.298%] [0.169–0.183%] [0.269–0.284%]
Zoonoses
Diagnosed cases 329,350 293,478 315,863 141,292 73,625 54,194 97,626
Death cases 17,354 35,607 29,295 12,528 4,496 8,161 11,420
Case fatality rate (%) 5.269% 12.133% 9.275% 8.867% 6.107% 15.060% 11.698%
[lower-upper limits] [5.152–5.386%] [11.952–12.313%] [9.120–9.429%] [8.640–9.094%] [5.842–6.371%] [14.599–15.520%] [11.390–12.007%]
Vector-borne diseases
Diagnosed cases 21,731,070 10,533,882 1,690,125 537,490 266,424 228,970 216,301
Death cases 37,200 19,283 13,262 7,081 4,232 2,863 1,375
Case fatality rate (%) 0.171% 0.183% 0.785% 1.317% 1.589% 1.250% 0.636%
[lower-upper limits] [0.169–0.174%] [0.179–0.187%] [0.764–0.805%] [1.271–1.364%] [1.516–1.661%] [1.181–1.320%] [0.584–0.687%]
Viral Hepatitis
Diagnosed cases 4,359,763 4,507,954 5,599,627 5,592,120 3,897,266 4,400,935 5,388,845
Death cases 9,158 9,950 10,463 6,656 4,616 4,572 4,657
Case fatality rate (%) 0.210% 0.221% 0.187% 0.119% 0.118% 0.104% 0.086%
[lower-upper limits] [0.203–0.217%] [0.214–0.227%] [0.181–0.192%] [0.115–0.123%] [0.113–0.124%] [0.099–0.108%] [0.083–0.090]
doi:10.1371/journal.pone.0031076.t001
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(Table 2).
Cholera has caused two major outbreaks in China in recent
decades: the first started in 1973, leading to a large peak in the
number of cases in 1980, with an annual notification rate of four
cases per 100,000 population (Figure 2a). The rate then gradually
subsided but there was a second major outbreak in the early 1990s.
During 2004 to 2008, cholera cases were reported at relatively low
incidence levels: the disease is well controlled, with a mean annual
decline in mortality due to the disease of 48% (95% CI, 12–70%,
Table 2).
Despite a 13-fold decrease in the epidemic haemorrhagic fever
notification rate since 1987 and continuous decline in the disease-
specific mortality rate, China is still the country most severely
affected by this disease, with 90% of the global cases of
haemorrhagic fever with renal syndrome (HFRS) occurring in
China [13,14]. HFRS remains an important public health issue in
China, as an estimated 20,000–50,000 new cases are reported
each year [15]. It is important to establish effective strategies to
reduce the incidence of HFRS. The mean annual decline in
mortality due to this disease is 12% (95% CI, 3–20%, Table 2).
Persistent public health campaigns have been effective in
reducing the number of rodents, which has been largely
responsible for the decreasing trend in plague and epidemic
haemorrhagic fever notifications. Improved hygiene and sanitary
conditions have also led to the decline in incidence and mortality
due to cholera.
Overall, these quarantinable diseases persist at low endemic
levels, but still pose potential threats.
Vaccine-preventable diseases
In the early 1960s, a nationwide vaccination programme was
implemented to eradicate smallpox, measles, poliomyelitis,
tuberculosis (TB), pertussis, diphtheria and tetanus. Measles
vaccine (one-dose schedule) was introduced in the country in
1965, and from 1978 it has been administered routinely to all
infants through the country’s expanded programme on immuni-
sation [16]. Measles mortality and morbidity has declined
continuously and substantially since 1978. During 1995 to 2007,
the incidence was less than one per 100,000 population (Figure 2b),
with fewer than 250 deaths due to measles reported annually [17].
However, limited small-scale outbreaks continue to occur among
susceptible children in rural areas with low routine immunisation
coverage and among susceptible children of ‘floating immigrants’
(the relatively large population of internal Chinese immigrants
who leave their rural hometown and move to urban areas to seek
better employment opportunities) [18]. In addition, although a
two-dose measles vaccination schedule has been recommended in
China since 1986, the second dose is widely perceived as a non-
mandatory booster. Coverage of the second dose is not reported,
but is thought to be low [19].
A global effort to eradicate polio began in 1988 [20]), wild-type
poliovirus was eradicated in China in 1994 [21,22]; extensive
surveillance for acute flaccid paralysis is thought to have strongly
contributed to polio eradication in the country [23].
Vaccination against diphtheria, pertussis and tetanus was also
made mandatory for all infants under the country’s expanded
immunisation programme since 1960s. In 2006, vaccination
coverage of the vaccine against the three diseases reached
99.0%, comparable with polio vaccination (99.0%) and measles
vaccination (98.6%) [24]. Since 2006, the total annual incidence of
reported cases of diphtheria, pertussis and tetanus decreased to
below 0.5 cases per 100,000 population (Figure 2b). Widespread
vaccination against these diseases is one of the important
contributors to improvements in child health in China: infant
mortality rate dropped from 20% in 1950 to 1.7% in 2006 [24].
Mandatory vaccination of children throughout the past decades
has been demonstrated to be successful in containing the spread of
these diseases in China. It is estimated that polio vaccination alone
has saved a total of 1,128,000 children in China from disabling
disease and suffering [24]. Mortality due to pertussis and tetanus
experienced significant annual decays at rates of 44% (95% CI,
23–59%) and 12% (95 CI%, 30–65%) (Table 2). Trends in TB are
discussed in the section on bacterial infections.
Gastrointestinal diseases
The number of reported cases of bacillary and amoebic
dysentery has declined rapidly since 1975 in China (Figure 2c).
An initial large decline occurred in the mid-1970s, largely due to
substantial improvements in sanitary conditions and quality of
drinking water. However, approximately 84 million diarrhoeal
episodes were still reported in China each year at the end of the
1990s: 25% of the episodes were in children under five years of age
[25]. Shigella bacilli and Entamoeba histolytica have been found to be
the main aetiological organisms [25]. A live oral Shigella vaccine
was then developed in 1997 in China, which provided 60–70%
protection against S. flexneri serotype 2a and S. sonnei infection [26].
Between 1999 and 2008, reported deaths due to dysentery
decreased by a mean of 10% (95 CI%, 1–18%) per year (Table 2).
The number of notified cases of typhoid and paratyphoid fevers
is very low in China, with an annual rate of 1.2 notifications per
100,000 population in 2008 (Figure 2c). The number of reported
deaths due to these infections has decreased at a mean rate of 22%
(95% CI, 2–39%) per year (Table 2). However, these infections
remain endemic in some rural areas of southern China, where
there is a lack of adequate sewage disposal and safe water supplies
[27]. A large, localised outbreak occurred during 1996 to 1998 in
Xing-An county in the southern province of Guangxi, which
resulted in an annual incidence rate of 39 to 103 cases per 100,000
population [28]. Subsequently 61,030 doses of Vi polysaccharide
vaccine were administered in 1999 and the epidemic quickly
subsided. No further typhoid fever outbreaks were reported in
China.
Vector-borne diseases and parasitic diseases
National public health campaigns since 1949 in China
effectively improved hygiene and sanitary conditions, which
substantially reduced most of vector-borne infectious diseases. In
1955, a total of 5,970,000 malaria cases were reported nationally,
accounting for 68% of the total number of reported infectious
disease cases and an incidence of 1,028 per 100,000 population.
Malaria disproportionately affected some regions, with incidence
rates as high as 10,360 per 100,000 population in Hainan province
[29]. In 1960 and 1970, there were major outbreaks of the disease,
leading to a national incidence of 1,554 and 2,961, respectively,
per 100,000 population [29]. It took considerable time for the
incidence to fall: the number of cases did not decrease to 1955
levels until 1982, but it has since continued to decrease. By 1998,
the rate of notifications decreased to 31.3 per 100,000 population,
corresponding to more than a 99% reduction and accounting for
only 1.3% of the total number of reported cases of notifiable
conditions [29]. Data for 2004 to 2008 indicate that the mean
annual mortality rate due to malaria was reduced to 0.004 per
100,000 population (Table 2), corresponding to only 52 reported
deaths per year countrywide. Malaria no longer represents a major
threat to the Chinese population. The ongoing government-
mobilised mass movement for vector control is probably an
effective method for eliminating mosquitoes and their habitats and
Trends in Infectious Diseases in China
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country. The universal healthcare system provided an effective
base for the implementation of countrywide interventions [6].
As a result of the national public health campaigns to eliminate
infectious disease vectors, forest encephalitis (also named Russian
spring-summer encephalitis), tick-borne relapsing fever, tsutsuga-
mushi disease (also known as scrub typhus) and epidemic typhus
were reduced to very low levels by the late 1980s and were then no
longer notifiable. The number of visceral leishmaniasis (also
known as kala-azar), Japanese encephalitis, malaria and dengue
fever epidemics has also decreased, with few cases per year
(Figure 2d). However, there are signs that climate change may
Table 2. Mortality rates and temporal trends in notifiable infectious diseases
a in China, 1999–2008.
Notifiable infectious diseases
Mean Annual Mortality rate per 100,000
population
Mean annual increase or decrease during 1999 to
2008
1999–2003 2004–2008 Percentage (%) 95% confidence interval
Quarantinable diseases
Plague 0.0100 0.0036 222 257 to +41
Cholera 0.0081 0.0002 248* 270 to 212




b 0 0 to 0
Measles 0.0101 0.0058 26 220 to +10
Pertussis 0.0081 0.0003 244* 259 to 223
Diphtheria 0.0080 0.0080 0 260 to +153
Tetanus 0.0323 0.0174 212* 22t o28
Gastrointestinal diseases
Bacillary and amoebic dysentery 0.0155 0.0087 210* 218 to 21
Typhoid fever/paratyphoid fever 0.0086 0.0029 222* 239 to 22
Vector-borne diseases
Epidemic/endemic typhus 0.0080 0.0001
{ 254 287 to +61
Japanese encephalitis (scrub typhus) 0.0254 0.0196 26 214 to +3
Visceral leishmaniasis (kala-azar) 0.0075 0.0035 25 269 to +20
Malaria 0.0087 0.0040 214 226 to +1
Dengue fever 0.0100 0.0051 242* 280 to +66
Zoonotic infections
Leptospirosis 0.0112 0.0040 220* 232 to 26
Brucellosis 0.0100 0.0035 224 264 to +63
Anthrax 0.0083 0.0025 231* 2100 to 21
Rabies 0.0753 0.2153 26* +14 to +37
Bacterial infections
Meningococcal meningitis 0.0099 0.0126 3 22t o+8
Scarlet fever 0.0080 0.0034 223 266 to +74
Tuberculosis 0.0580 0.2244 28* +14 to +43
Sexually transmitted infections
HIV infection 0.0285 0.2185 44* 30 to 58
Gonorrhoea 0.0100 0.0002 249* 263 to 230
Syphilis 0.0083 0.0059 24 219 to +15
Viral hepatitis
All 0.0697 0.0897 5* 2 to 8
Hepatitis A 0.0059 0.0025 221* 232 to 28
Hepatitis B 0.0473 0.0642 9* 1 to 20
Hepatitis C 0.0027 0.0076 30* 16 to 46
Hepatitis E 0.0019 0.0031 9 23t o+24
AIDS: acquired immunodeficiency syndrome; HIV: human immunodeficiency virus.
*Denotes a statistically significant (p,0.05) mean annual increase or decrease of disease-specific mortality rates during 1999 to 2008.
aGroup A and B notifiable diseases.
bThe detection limit of the mortality rate is 0.0001 per 100,000 population.
doi:10.1371/journal.pone.0031076.t002
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a in China by category of disease, 1975–2008.
doi:10.1371/journal.pone.0031076.g002
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the past decade in China [30].
Zoonotic infections
Rabies is one of the zoonotic diseases on the rise in China.
During a 58-year period between 1950 and 2007, a total of
117,530 human rabies cases were reported, corresponding to an
incidence rate of 9.1 cases per 100,000 population. Three major
epidemics were observed [31,32]: the first occurred in the mid-
1950s when the annual number of reported cases reached a peak
of about 2,000. The epidemic subsided in the 1960s and then
started to surge again in the early 1970s. After reaching a sustained
peak from 1982 until the end of the decade, at a level of 5,000 to
6,000 cases per year [33], in 1996 the number of cases was at its
lowest, with 159 reported cases [33]. As the disease in humans is
closely associated with transmission of rabies virus by infected
dogs, in the past epidemics, strict policies for vaccination of owned
dogs and elimination of stray dogs were put in place, resulting in
effective control of the epidemic. However, since 2000, due to a
new wave of rapid expansion of the pet dog population in urban
China, there has been a third outbreak, in which the number of
cases has increased rapidly: in 2007, the number of notified cases
climbed to 3,250 [34,35]. The rabies-related mortality rate
increased during 1999 to 2008 by a mean of 26% (95% CI, 14–
37%) per year (Table 2). This should serve as a call for action to
prevent the further spread of rabies in China.
Severe acute respiratory syndrome (SARS), caused by a
coronavirus that was transmitted to humans through close contact
with civet cats, spread from Guangdong, China, quickly leading to
a worldwide epidemic in 2003. China reported 5,327 (66%) of the
8,071 SARS cases globally and 349 SARS-related deaths during
the epidemic, which lasted for approximately a year [36].
The first human case of highly pathogenic avian influenza A
(H5N1) virus infection was reported in Hong Kong in 1997. By
2009, mainland China had 88 avian influenza outbreaks among
birds in 23 provinces and a total of 38 human cases and 25 deaths
had been reported [37]. In 2010, the epidemic had spread to 15
countries and resulted in 296 deaths, out of 500 cases [38]. In
comparison, the 2009 influenza A(H1N1) pandemic caused more
than 154,000 human cases and 842 deaths in China alone [39],
despite the virus being much less virulent than influenza A(H5N1)
virus. China, with concentrated human activity in its fast-growing
major cities that may lead to effective transmission of human-to-
human transmission of H1N1, is very vulnerable to the
transmission of respiratory infectious diseases of zoonotic origin.
During the mid-to-late stages of the SARS outbreak and, more
apparently throughout the course of the 2009 influenza pandemic,
the Chinese Government responded swiftly with openness and
transparency to control both diseases and prevent further episodes.
In both cases, the epidemics caused widespread social panic.
Instead of the Ministry of Health, the State Councils –
representing the highest administrative authority of the Chinese
Government – assumed direct leadership in combating the
epidemics.
Case notifications for leptospirosis, anthrax and brucellosis have
remained at low levels since 2000. There was an increase in the
number of notified case of brucellosis from 0.17 per 100,000
population in 2000 to 1.50 per 100,000 population in 2007, but
this was probably due to improved surveillance and is believed not
to reflect an increase in incidence [40]. The annual number of
notified cases of leptospriosis and anthrax dropped below 0.01 per
100,000 population in 2008. The mortality rate due to brucellosis
remains very low and stable, whereas the rates due to leptospriosis
and anthrax have dropped significantly, by 20% and 31%,
respectively, during 1999 to 2008 (Table 2).
Bacterial infections
China has the second largest TB epidemic in the world (after
India) [41]. In 2008, some 4,500,000 patients were living with
pulmonary TB in China, corresponding to an incidence of 111 per
100,000 population, and resulting in 130,000 deaths from TB in
the same year [42]. Since 2005, an estimated 20,000 additional
TB reactivation cases have arisen per annum in China due to
human immunodeficiency (HIV) coinfection [42].
The TB epidemic has spread unevenly in China: in 2005, China
reported a national TB prevalence of 0.2% [41], whereas the
southern province of Guangxi, which borders Vietnam, reported a
much higher prevalence of 0.65% [43]. In 1991, in adopting
DOTS – the internationally recommended TB control strategy –
China launched a 10-year infectious and endemic disease control
project in an effort to curb its expanding TB epidemic in 13 of its
31 provinces [44,45]. It is estimated that the number of Chinese
people infected with TB between 1990 and 2000 decreased by
30% and that 300,000 TB deaths were averted. With a success
rate greater than 90% [45], DOTS has led to the avoidance of an
estimated 1.5 million TB cases [44,45]. However, since 2000,
multidrug-resistant (MDR) TB and extensively drug-resistant
(XDR) TB have emerged as a severe public health issue in the
country. In 2004, China reported approximately 140,000 MDR
TB cases, accounting for about one third of the estimated global
burden of MDR TB [46]. In some provinces, the proportion of
MDR TB among newly notified TB cases and previously treated
cases was found to exceed 10% and 30%, respectively [47]. The
latest study indicates that the prevalence of MDR TB among TB
patients is as high as 19.4%, and 14.9% of MDR TB cases were
XDR during 2007 to 2009 [48]. The mortality due to TB
increased at a rate of 28% (95% CI, 14–43%) per year.
Hydroelectric projects that led to the formation of a large
number of dams in China, as well as climate change, have
substantially increased the risk of schistosomiasis occurring and its
spread to non-endemic areas of the country, leading to small-scale
outbreaks and increases in rates of case notifications near the
affected areas [49,50]. The incidence of schistosomiasis has
increased from 0.10 cases per 100,000 population in 2004 to
0.26 per 100,000 population in 2008 (Figure 2f).
HIV and other sexually transmitted infections
Since the founding of China in 1949, laws have been enacted to
make commercial sex illegal. Brothels were closed down and sex
workers were sent to camps to be ‘re-educated’. Special institutions
for treatment of sexually transmitted infections (STIs), at the time
mostly syphilis, gonorrhoea and Chlamydia, were established for
the training of medical personnel, who were then sent to areas
previously associated with large sex industries to treat STIs at
beginning of 1950s. During 1950s, a universal healthcare system
was established that provides treatment for STI patients free of
charge. Designated laboratories for STIs were built for diagnosis
and research [51]. More importantly, population-based health
education campaigns about STIs were carried out, and detection
and treatment of STIs were portrayed as patriotic actions [52]. As
a result, the number of cases of notifiable STIs decreased from 10
million in 1950 to reportedly eliminated from 1964 [51,53,54].
However, notifiable STIs have re-emerged, leading to a fast-
spreading epidemic in the country. In 1987, the incidence for STIs
was 6.64 per 100,000 population and in 1996, the rate increased to
34.6 per 100,000 population, which corresponded to 1.8 million
new STI cases [52]. The annual growth rate of the number of STI
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mainly due to unprotected sexual acts and other high-risk
behaviours [55,56].
Since early 1980s, underground prostitution has again become
rampant in major cities in China [57]. The number of Chinese
men, increased purchasing power of urban residents and trends
away from traditional Chinese family values of fidelity all led to an
increased number of male clients for commercial sexual services
[58]. In addition, lack of sexual health knowledge among
commercial sex workers and their inability to effectively negotiate
condom use during sexual acts substantially increased the risk of
STI transmission [57,59]. The previously hidden population of
men who have sex men (MSM) is becoming more overt due to
increasing acceptance in society. High-risk sexual behaviours,
including a low percentage of condom use, in this population is
also contributing to the fast transmission of STIs [60]. For
example, in 1998, the incidence of syphilis in China was 0.17 per
100,000 population: it increased 20-fold to 4.31 cases per 100,000
population in 2002 and further to 15.88 cases per 100,000
population in 2007 [10,51] (Figure 2g). In particular, MSM,
injecting drug users (IDUs) and female sex workers have the
highest syphilis prevalence in China, of 10–20% [61,62], 5.4%
[63] and 7–12% [64], respectively.
The first case of acquired immunodeficiency syndrome (AIDS)
in China was reported in 1985, but a local HIV epidemic was not
detected until 1989 when a cluster of infections was diagnosed
among IDUs in Yunnan province [65]. Before 2000, China had
fewer than 20,000 reported HIV/AIDS cases, but in 2007, the
number rose to 200,000. The latest estimates are that 700,000
people were living with HIV/AIDS in China at the end of 2007,
with 70,000 new infections added every year since then [66] and
20,000–30,000 annual AIDS-related deaths [67]. Although the
HIV/AIDS epidemic first began and predominated among IDUs,
it rapidly spread to other population groups through both
heterosexual and homosexual transmission. The latest figures
demonstrate that heterosexual transmission has accounted for
approximately 38–50% of new HIV infections since 2005 [68],
which may level at or exceed the percentage (30–49%) caused by
transmission due to the sharing of injection equipment among
IDUs [69,70]. Notably, HIV infection has become more prevalent
among MSM, as male homosexual activities account for
approximately 10% of new infections [71]. AIDS mortality rate
increased from 0.10 in 1999 to 1.01 cases per million in 2005, then
to 4.58 cases per million in 2008, corresponding to an annual
growth rate of 44% (95% CI, 30–58%) the rate is expected to
increase sharply if the epidemic remains uncontrolled and there is
no large procurement of antiretroviral drugs. Cumulatively, over
9000 infants were infected through mother-to-child transmission
by 2005 and it was estimated that about 500 million Chinese were
carriers of Mycobacterium tuberculosis in 2003 [72]: coinfection of
HIV and M. tuberculosis could therefore have a large epidemiolog-
ical impact, in the absence of appropriate public health
interventions.
Viral hepatitis
Viral hepatitis is prevalent in China, but the prevalence differs
according to the type of virus. Before the 1990s, hepatitis A virus
(HAV) was the most prevalent. In the early 1990s, the annual
number of reported HAV diagnoses was more than 50 per
100,000 population. This dropped by 90% to 5 per 100,000
population in 2005 to 2006 [73] (Figure 2h). The mean annual
death rate due to HAV decreased at a rate of 21% (95% CI, 8–
32%) during 1999 to 2008 (Table 2). The decrease is probably a
result of mass vaccination efforts in introducing the HAV vaccine
(H2 strain) in the 1990s and improvement of hygiene and sanitary
conditions that broke the cycle of food and water contamination
[73]. According to 2008 data [74], HAV persists at low, endemic
levels (Figure 2h). In comparison, infections of hepatitis B virus
(HBV), which is transmitted mainly through body fluid from
mother to child, and hepatitis C virus (HCV), transmitted
predominantly by intravenous injections or blood transfusion,
are becoming alarmingly widespread in China. The annual
number of new HBV cases increased rapidly from 20 per
100,000 population in 1990 and reached 100 per 100,000
population in 2008, despite an increasing vaccination coverage
of newborns from 30% in 1992 to 93.4% in 2005 [75]. HCV
infections followed a similar trend and in 2007, the annual
notification rate was about 8.8 per 100,000 population. The 2007
HCV and HBV prevalence among the general population was
0.5% and 6%, respectively [74]. Mortality due to HBV and HCV
increased at annual rates 9% (95% CI, 1–20%) and 30% (16–
46%) respectively.
In contrast to HAV infection, which always causes acute
hepatitis but never develops into a chronic condition, HCV and
HBV infections often cause chronic hepatitis and may develop into
cirrhosis and hepatocellular carcinoma [76]. Coinfection of HBV
or HCV with other pathogens causing chronic infections, such as
HIV, results in substantial increases in the disease burden on
individuals, accelerates disease progression and complicates
treatment [77,78]. Since HBV and HCV can both be transmitted
through exchange of body fluids, coinfection of these hepatitis
viruses with HIV is common in at-risk groups in China.
Approximately 67–71% of the 700,000 registered IDUs in China
are infected with HCV [79,80,81] and 17–26% of them are
infected with HBV [79,82]. The prevalence of HIV/HCV
coinfection is 6.45% in IDUs [80]. Among blood donors, the
prevalence of HIV/HCV coinfection is 5.8–6.5% [80,83],
whereas the figure for HIV/HBV coinfection is 3.7% [84]. In
comparison, coinfection of HIV and HCV among the general
population remains unknown as there is currently no reports on its
prevalence. However, coinfection is expected to be increasingly
noticeable as the HIV epidemic transforms into a generalised
epidemic in China [6].
Implications of disease surveillance and interventions in
China
Overall, this study investigated the temporal trends of major
types of notifiable infectious diseases in China. Our analysis
indicated that while the morbidity and mortality of most infectious
diseases reduced substantially during 1975–1995, there is an
increasing trend of re-emergence of previously prevalent diseases
and emergence of new infectious diseases since 1995, in particular,
STIs and HIV, viral hepatitis and zoonoses diseases. These
diseases accounted for the majority of deaths associated with
infectious diseases in China since 2005. Consistent with this,
analysis of case fatality rates indicated a higher percentage of
deaths among zoonotically infected people (5–15%) and an
elevated proportion (0.894%) among STIs and HIV-infected
individuals. Our study has important implications for the
surveillance and control of infectious diseases in China. First, the
persistent small outbreaks of particular infectious diseases across
the country indicate that any decrease in prevention efforts will
probably trigger re-emergence of the diseases. Surveillance
activities are therefore essential to inform and prioritise public
health responses. Although efficient and well-developed disease
surveillance systems have been implemented in many urban areas,
hygiene conditions, health services and monitoring of patterns of
spread and disease burden are largely lacking in rural China [6].
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especially HIV infection, and viral hepatitis in China is associated
with growth of the sex industry, increasingly frequent risky sexual
behaviours and an increasing number of sexual partners in the
general Chinese population. The newly implemented internet-
based National Infectious Diseases Monitoring Information
System Database not only provides a platform for integrating
epidemiological data on HIV infection and other STIs, but also
initiated second-generation behavioural surveillance of the at-risk
populations [70]. Our analysis indicates that both epidemiological
and behavioural surveillance of HIV infection and other STIs is
essential to understand and forecast the trends in these epidemics.
Extending surveillance efforts into population groups that were
previously considered to be less at risk may further improve the
quality and reliability of surveillance data.
Third, coinfections, especially those involving HIV, are likely to
become major public health issues in the future. We demonstrate
that TB/HIV, HBV/HIV and HCV/HIV coinfections have
become increasingly prevalent in China and the trend is likely to
continue in the absence of strong public health interventions.
Thus, inclusion of testing for TB and viral hepatitis coinfections as
part of HIV voluntary counselling and testing could be useful
among at-risk populations. Scaling up of free-of-charge antiretro-
viral therapy should also include treatment for these coinfections.
Fourth, surveillance of zoonotic infections becomes increasingly
important due to the interactions between humans and animals in
China. China has established an efficient surveillance system for
human infectious diseases [6,85]: a parallel national centralised
system for surveillance of disease in animals may be useful for
reducing the risk of animal-to-human transmission.
One of the potential limitations in our investigation may be
poor data quality in the passive notification-based surveillance
system. It is widely perceived that underreporting exists in the
Chinese infectious diseases surveillance system, but little is known
about the extent of underreporting as systematic evaluations have
never been conducted [6]. This issue requires further consider-
ation in the future. An overview of prevalence studies would be
useful for comparison with numbers of notified cases in order to
estimate numbers of undiagnosed cases. A comprehensive
evaluation would also involve assessments of the efficiency and
effectiveness of the surveillance system, both quantitative and
qualitative. Understanding changes in testing rates in various
population groups will also be useful for interpreting trends in
notification data. But such investigations are beyond the scope of
this review.
Future challenges
Infectious disease surveillance and interventions in China face
several major challenges. The country’s major economic reform in
1979 has created a large economic disparity between rural and
urban areas, resulting in a large population of floating immigrants
(also known as ‘peasant workers’). This accounts for 10% of the
total Chinese population in 2005 [86]. The vast majority of these
immigrants are from rural environments but work in urban areas,
away from their families, and hence regularly travel between the
two sites. In addition to the natural population growth of major
cities, the inflow of internal immigrants substantially increases the
population size and density in urban areas. These immigrants
often live in overcrowded residential areas with compromised
hygiene conditions. Female immigrants often become targets of
those seeking to recruit them for commercial sex work [57,87].
These floating immigrants are often more disadvantageous than
the local residents. They tend to be less educated compared with
others in urban areas who have permanent resident status and less
likely to seek medical treatment when sick due to financial
constraints or lack of health insurance [6]. Not surprisingly, the
population of floating immigrants has been found to be more
vulnerable to infectious diseases, especially STIs, HIV and viral
hepatitis [6]. Additionally, their high-risk behaviours and mobility
promotes transmission of infectious disease agents and creates a
major challenge for disease detection and control. Given the
characteristics, behaviours and the increasing population size of
floating immigrants, it becomes apparent that the capacity of
current Chinese healthcare system cannot meet the needs of both
the surveillance activities and health problems of these migrant
workers. The infectious disease surveillance system needs to be
tailored for its high mobility, and a dramatic expansion of the
private health sector is required to address the health needs of this
population.
Transmission of zoonotic infectious agents relies on close
interaction between infected animals and humans. As a result of
the increasing social trend of keeping house pet dogs, it is
estimated that the number of pet dogs in China reached 80–200
million in 2004 [88]. However, only 30% of dog owners register
their animals with government authorities and only 2–8% of
dogs are vaccinated against rabies [31,89] – coverage of greater
than 70% is needed to sufficiently control rabies, as determined
by the World Health Organization (WHO) [90]. The high rabies
prevalence (6.4%) among dogs and the expanding number of pet
dogs pose a continual and increasing threat of transmission of
rabies virus from dogs to humans in China [89]. In addition, the
consumption of game meat, especially in southern China, is one
of the important sources of zoonotic diseases [91]. Markets in
Guangdong provinces sell live poultry, fish, reptiles and
mammals, including dogs and civet cats, for food [92]: the
housing of these live animals, often in packed conditions,
together with human activities, makes such markets the ideal
hub for cross-species transmission of zoonotic agents [91]. Since
there is no systematic surveillance of these live markets, it is
difficult to estimate the number of such markets and the amount
of game meat consumed by residents in southern China. The
SARS epidemic in 2003 demonstrates that transmission of
pathogens originally associated with animals can cause world-
wide outbreaks in human populations. The current absence of
both epidemiological and behavioural data, including their
frequency of contacts and means of animal handling, on animal
infectious diseases is a strong barrier to effective surveillance and
control.
Environmental changes facilitate the emergence and transmis-
sion of bacterial infections. The formation of a large number of
dams in China, as a result of the increasing implementation of
hydroelectric projects, have substantially increased the risk of
schistosomiasis emergence and its spread to non-endemic areas of
the country. Further, the dense population conditions in urban
China and the high mobility of its floating migrants substantially
promote the rapid transmission of tuberculosis [93]. Strengthening
infectious diseases surveillance for bacterial infections among these
specific affected populations should be a priority for the Chinese
government.
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